Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

NCT05488431 is registered in ClinicalTrials.gov with Priscilla Hsue, MD as lead sponsor.

NCT NCT05488431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05488431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
Lead sponsor
Priscilla Hsue, MD
Phase
Phase 2
Overall status
Recruiting
Start date
March 1, 2023
Completion date
March 1, 2028
Enrollment
121 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, cardiovascular diseases, dyslipidemias, hiv infections